Blue Jet Healthcare commissions multi- product Production block at Ambernath Unit 2 facility

01 Jul 2024 Evaluate

Blue Jet Healthcare has successfully completed commissioning of multi- product Production block to manufacture pharma intermediates at its existing Unit 2 facility situated at Ambernath, Maharashtra, India. The company has commenced manufacturing of Validation Batches with effect from June 29, 2024. The current capacity utilization is around 70% of the existing capacity. The company is proposed to commercialize full scale production within next six months. Total investment incurred is Rs 90 crore.

The Mumbai-based Blue Jet Healthcare is a specialty pharmaceutical and healthcare ingredient and intermediate company, offering niche products targeted towards innovator pharmaceutical companies and multinational generic pharmaceutical companies.


Blue Jet Healthcare Share Price

545.00 -10.40 (-1.87%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×